The vertebrate craniofacial skeleton develops via a complex process involving signaling cascades in all three germ layers. Fibroblast growth factor (FGF) signaling is essential for several steps in pharyngeal arch development. In zebrafish, Fgf3 and Fgf8 in the mesoderm and hindbrain have an early role to pattern the pouch endoderm, influencing craniofacial integrity. Endodermal FGF signaling is required for the differentiation and survival of postmigratory neural crest cells that form the pharyngeal skeleton. We identify a novel role for zebrafish Fgf receptor-like 1a (Fgfrl1a) that is indispensable during gill cartilage development. We show that depletion of Fgfrl1a is sufficient to abolish cartilage derivatives of the ceratobranchials. Using an Fgfrl1a-deficient model, we analyzed expression of genes critical for chondrogenesis in the different compartments of the developing pharyngeal arch. Fgfrl1a-depleted animals demonstrate typical neural crest specification and migration to populate the arch primordia as well as normal pouch segmentation. However, in the absence of Fgfrl1a, larvae fail to express the transcription factor glial cells missing 2 (gcm2), a gene necessary for cartilage and gill filament formation, in the ectodermal lining of the branchial arches. In addition, two transcription factors essential for chondrogenesis, sox9a and runx2b, fail to express within the mesenchymal condensations of the branchial arches. A duplicate zebrafish gene, fgfrl1b, has now been identified. We show that Fgfrl1b is also required for proper formation of all ventral cartilage elements and acts cooperatively with Fgfrl1a during gill cartilage formation.
Introduction
Our understanding of the critical roles that fibroblast growth factor receptors (FGFRs) play in skeletal formation has in part been revealed through analysis of mutations in these receptors that lead to more than 15 human disorders involving cartilage and/or bone dysplasia (Coumoul and Deng, 2003; Rice et al., 2003) . FGFRs belong to a family of highly conserved transmembrane tyrosine kinases that serve as high affinity receptors for FGFs. To date, four FGFRs have been identified, whereas there are at least 23 FGF ligands (Itoh and Ornitz, 2004) . The involvement of FGF signaling in a number of cellular and tissue processes affecting different target cells is in part achieved by variation at the level of the receptor. Apart from differential spatio-temporal expression of the receptor genes, alternate splicing of FGFR mRNA confers selective ligand-binding properties of the variant receptors, thus expanding functional diversity (reviewed by Ornitz and Marie, 2002) . Furthermore, positive and negative regulators that can act either directly or by recruiting other cofactors, are important in modulating signal outcome (Tsang and Dawid, 2004) . Examples include xFLRT3 that forms a complex with FGFRs and serves as an FGF signal enhancer in Xenopus (Bottcher et al., 2004) , and the transmembrane protein Sef that interacts with FGFR1 and functions as a negative feedback regulator of FGF signaling in zebrafish and mice (Furthauer et al., 2001; Furthauer et al., 2002; Tsang et al., 2002) . Identifying novel modulators will likely provide a more complete picture of the complex mechanisms involved in FGF signal transduction.
Development of the zebrafish craniofacial skeleton has been studied in our laboratory and others Yelick and Schilling, 2002; Clouthier and Schilling, 2004; Flores et al., 2004) , and presents an opportunity to dissect FGF signaling pathways further (David et al., 2002; Ornitz and Marie, 2002; Nissen et al., 2003; Rice et al., 2003; Trokovic et al., 2003; Walshe and Mason, 2003; Crump et al., 2004) . Here, we investigated the role of zebrafish Fgf receptor-like 1a (Fgfrl1a) during pharyngeal cartilage formation. The human, rat, chicken, Xenopus and zebrafish FGFRL1 genes have been previously characterized (Wiedemann and Trueb, 2000; Kim et al., 2001; Sleeman et al., 2001; Wiedemann and Trueb, 2001; Trueb et al., 2003; Hayashi et al., 2004) . Zebrafish and Fugu rubripes possess two copies of the fgfrl1 gene (fgfrl1a and fgfrl1b), with fgfrl1a more closely related to the mammalian gene (Trueb et al., 2005) . In all species, the predicted FGFRL1 extracellular and transmembrane domains are highly related to members of the FGFR family, yet the intracellular protein tyrosine kinase domain required for signal transduction in FGFRs is absent. Human FGFRL1 is abundantly, but not exclusively, expressed in skeletal tissues. Overexpression of FGFRL1 in an osteosarcoma cell line led to decreased cell proliferation and raised the possibility that it may act as a decoy receptor for FGF ligands (Trueb et al., 2003) . Expression studies in mice show that Fgfrl1 is expressed within cartilaginous structures including the primordia of bones and permanent cartilage of the trachea (Trueb and Taeschler, 2006) . In Xenopus, transcripts for xfgfrl1 and xfgf8 are co-localized in the endodermal pouches of the pharyngeal arches, raising the possibility of cooperative involvement in development of the pharyngeal arches (Hayashi et al., 2004) . To date, no functional in vivo data has been reported for FGFRL1 in any vertebrate model system.
The pharyngeal arches comprise a range of cell types from different developmental origins. Cells originating from the cranial neural crest and mesoderm make up the core, while the outer epithelium is endodermally and ectodermally derived (Ornitz and Marie, 2002) . In zebrafish, endodermal Fgf3 and Fgf8 are essential for pharyngeal cartilage formation. The fgf8 mutant acerebellar (ace) (Reifers et al., 1998) and Fgf8 morphants (Walshe and Mason, 2003; Crump et al., 2004) have mildly dysmorphic mandibular and/or hyoid arches; though all skeletal elements are present. In contrast, the fgf3 mutant lims absent (lia) (Herzog et al., 2004) , and Fgf3 morphants (David et al., 2002; Walshe and Mason, 2003; Hanaoka et al., 2004) display ceratobranchial (cb) cartilage elements that are either significantly reduced or absent for arches three to six (cb1-4). Depletion of both Fgf3 and Fgf8 leads to a nearly complete loss of head cartilage derivatives, indicating redundant but essential roles for these two ligands (Walshe and Mason, 2003; Crump et al., 2004) . Fgf3 and Fgf8 from the mesoderm and hindbrain have been shown to be key organizers of endodermal pouch segmentation, pointing to an early function of these proteins in a process that will influence pharyngeal skeletogenesis (Crump et al., 2004) . We sought to uncover at which step in this process Fgfrl1a might act.
We report a detailed analysis of the expression of zebrafish fgfrl1a in relation to the developing craniofacial skeleton, and provide the first in vivo evidence for a function of this molecule during gill cartilage formation. Using loss-offunction experiments and analysis of epistatic genes, we demonstrate that zebrafish Fgfrl1a is essential for proper craniofacial skeletogenesis, particularly that involving the posterior arches. While Fgfrl1a morphants resemble the fgf3 mutant lia (Herzog et al., 2004) , we delineate a role for Fgfrl1a during ceratobranchial cartilage formation that is independent of neural crest migration and pouch endoderm segmentation. The transcription factor Glial cells missing 2 (Gcm2) has been demonstrated to be essential for both pharyngeal skeletogenesis and gill bud formation in zebrafish, downstream of an Fgf3-responsive pathway (Hanaoka et al., 2004; Hogan et al., 2004; Okabe and Graham, 2004) . Our studies show that, like Fgf3, Fgfrl1a is necessary for the expression of gcm2 in the pharyngeal ectoderm. We demonstrate that the branchial arches in Fgfrl1a-deficient animals fail to complete chondrogenesis, corroborated by loss of expression of two transcription factors essential for this process, sox9a and runx2b. Information regarding the duplicated zebrafish fgfrl1 genes came when this work was nearing completion. Hence, we also investigated whether fgfrl1b, which is also expressed in the pharyngeal pouches, participates during gill cartilage development. In Fgfrl1b-depleted animals, as in those deficient for Fgfrl1a, ceratobranchial cartilage elements were either absent or severely reduced. However, unlike Fgfrl1a-depleted animals, Fgfrl1b morphants also displayed a dose-dependent ablation of arch 1-and 2-derived cartilage elements. We thus identify Fgfrl1a and 1b as being indispensable for cartilage formation within the branchial arches.
Results

Comparative analysis of the FGFRL1 gene sequences
The sequences encoding zebrafish Fgfrl1a and 1b had been previously deposited in GenBank (Accession Nos. AJ574916 and AJ781308) and for this study were isolated by RT-PCR (see Section 4). ClustalW alignment between human, rat, mouse, chicken and Xenopus FGFRL1 and the predicted zebrafish orthologs, Fgfrl1a and 1b, revealed a high degree of amino acid identity within the extracellular regions which contain three Ig-like domains, and the transmembrane domains (Fig. 1A) . In contrast, the intracellular regions shared little overall identity. The murine FGFRL1 ortholog has been reported to possess two SHP-like binding motifs (Sleeman et al., 2001) . SHPs are protein tyrosine phosphatases that participate in a number of signaling cascades, including those mediated by growth factors (Feng, 1999) . It has been suggested that, although the FGFRL1 motif does not strictly adhere to the SHP consensus, it may impart some signaling potential. This region of the protein (residues 458-467 of the murine sequence) displays the greatest degree of similarity within the intracellular domain among the vertebrate orthologs. In addition, the two conserved tyrosine residues associated with these SHP-like domains are present within zebrafish Fgfrl1a and 1b (Fig. 1A) .
Phylogenetic analysis, based on full-length amino acid sequences, revealed that the FGFRL1 orthologs cluster into a clade, distinct from those representing members of the closely related FGFR family (Fig. 1B) . Furthermore, zebrafish Fgfrl1a was more closely related to mammalian, chicken and Xenopus FGFRL1 than was Fgfrl1b, supporting the analyses performed by Trueb et al. (2005) .
Embryonic expression of fgfrl1a is dynamic
fgfrl1a expression was first detected as a zygotic transcript at the 10 somite stage. Maternal transcripts were not detected by RT-PCR (data not shown). This earliest expression was limited to the developing forebrain, notochord and flanking somites ( Fig. 2A and B) . By the 18 somite stage, forebrain expression was restricted to the telencephalon while the somitic domain became largely confined to the posterior-most somites (Fig. 2C and D) . Also at this time, fgfrl1a expression was weakly detected at the midbrain-hindbrain boundary (Fig. 2C) . At 24 hpf, forebrain expression expanded to include not only the ventral telencephalon but also the ventral diencephalon ( Fig. 2E and F) . In addition, transcripts remained detectable at the midbrain-hindbrain boundary and in posterior somites ( Fig. 2E and F) . At this stage, fgfrl1a was also expressed in the otic vesicles and pharyngeal pouch endoderm ( Fig. 2E and F) . By 36 hpf transcripts were detected within epithelial cells lining the developing lens (Fig. 2G) . At 48 hpf, fgfrl1a transcripts persisted in the pharyngeal pouches (Fig. 2H) . fgfrl1a-expressing cells were also detected lining the heart tube ( Fig. 2H, inset ) and within the pectoral fin bud (Fig. 2I) . Also within the 48 hpf embryo, a new domain of expression commenced that marked the intestinal bulb primordium (Fig. 2J) . In the trunk, transcripts marked the posterior somitic boundaries, the peri-anal region and a diffuse collection of cells, presumed ectodermal, lining the dorsal neural tube (Fig. 2K) . By 56 hpf, expression had diminished within the branchial arches but strongly highlighted the mandibular and hyoid arches (Fig. 2L) . Within 4 dpf larvae, as well as still being associated with the developing pharyngeal skeleton, cells expressing fgfrl1a were detected in the liver and lining the entire intestinal bulb (Fig. 2M) .
Previous investigations into Fgfrl1 expression within other model systems have highlighted the conservation of expression within skeletal/cartilaginous domains and their precursor structures (Wiedemann and Trueb, 2000; Trueb et al., 2003; Hayashi et al., 2004; Trueb and Taeschler, 2006) . Although no in vivo functional studies have been published to date, such strong conservation of expression Abbreviations: An, anus; E, eye; Ec, ectoderm; FBr, forebrain; H, hyoid arch; HT, heart tube; IB, intestinal bulb; IBP, intestinal bulb primordium; Le, lens; Li, liver; M, mandibular arch; MHB, midbrainhindbrain boundary; N, notochord; OV, otic vesicle; PFB, pectoral fin bud; PP, pharyngeal pouches; So, somites; SoB, somite boundaries; Te, telencephalon; VD, ventral diencephalon; VT, ventral telencephalon. Scale bars: 250 lm in A-F, H, I and K-M; 100 lm in G and J.
within these cell types argues for a conserved function during their development. We therefore decided to further explore the early pharyngeal component of fgfrl1a expression. Analyzing fgfrl1a expression within sectioned 36 hpf embryos, and comparison with similar sections labeled with Zn5, an antibody that marks pouch endoderm (Trevarrow et al., 1990) , confirmed that fgfrl1a was expressed by pharyngeal pouch endoderm, as well as a subset of dorsal neural crest cells associated with the first two arches (Fig. 3A-D) . To further establish that the early stripes of fgfrl1a-expressing cells within the pharyngeal region represented pharyngeal pouch endoderm, we analyzed fgfrl1a expression in one-eyed pinhead (Oep)-depleted embryos. Embryos deficient in Oep lack shh and axial expression in the pharyngeal pouch endoderm, consistent with an early requirement for Oep in endoderm formation (Schier et al., 1997) . Oep-depleted embryos lacked the pharyngeal pouch domain of fgfrl1a expression, suggesting this expression is within cells of endodermal origin ( Fig. 3E and F) . Analyzing fgfrl1a expression within sectioned larvae at 56 hpf revealed that transcripts were present within neural crest-derived mesenchyme associated with the mandibular and hyoid arches ( Fig. 3G and H) but were no longer detectable within the endodermal pouches of the branchial arches (data not shown).
Fgfrl1a is essential for cartilage formation within the posterior pharyngeal arches
To explore a possible requirement for Fgfrl1a during zebrafish craniofacial development we took advantage of the ability of splice-blocking MOs (SBMOs) to interfere with splicing of specifically targeted pre-mRNAs (Draper et al., 2001; Hans et al., 2004) . A SBMO was designed to target the splice donor site immediately downstream of the exon encoding the second Ig-like domain (Fig. 4A ). This splice site was targeted because the second Ig-like domain is predicted to be involved in ligand binding (G. Murison, unpublished) .
To characterize the efficacy of this SBMO following early delivery into zebrafish embryos, we used semi-quantitative RT-PCR to detect altered splicing using primers within the neighboring exons (Fig. 4A ). Injection of a 1.0 pmol dose resulted in a near complete loss of normally spliced fgfrl1a. When the dosage was increased to 1.5 pmol, correctly spliced product was barely detectable (Fig. 4B) . Injected embryos at both doses possessed unaltered transcript levels for the controls, fgfrl1b and ef1-a (Fig. 4B ). Amplification using a primer complementary to intronic sequence located immediately downstream of the SBMO target site generated a product when using cDNA isolated from 1aSBMO-injected animals. This suggested that intronic sequence between the Ig2-and Ig3-encoding exons was not correctly removed in the presence of the 1aSBMO. Inclusion of this intronic sequence would result in a truncation of Fgfrl1a immediately downstream of the second Iglike domain (Fig. 4C ).
Early delivery of this fgfrl1a-targeting 1aSBMO into zebrafish embryos resulted in a consistent and specific phenotype. Injected embryos (1.0 pmol dose) displayed subtle developmental defects during the first 2 days of development including retardation of eye development, first detected around 24 hpf, and an expansion of the brain ventricles (Fig. S1 ). However, by 4 dpf, the eyes and jaw of Fgfrl1a morphants were grossly dysmorphic ( Fig. 4D and E). To analyze the underlying craniofacial defect responsible for the dysmorphic jaw, 4 dpf morphant larvae were stained with alcian blue. This revealed highly specific abnormalities in ventral cartilage development, with loss or incomplete formation of the five ceratobranchial cartilage elements (83/126 at 1.0 pmol dose; 70/74 at 1.5 pmol dose) ( Fig. 4F-I ). However, the more anterior elements derived from the first two arches (Meckel's, palatoquadrate and hyoid cartilages) were always present, albeit slightly misshapen (Fig. 4F and G) . Closer examination of the branchial region of Fgfrl1a-depleted animals revealed that in some instances a few stacked chondrocytes were present (Fig. 4I) . Cartilage comprising the neurocranium remained largely unaffected in the absence of Fgfrl1a with all elements present, albeit slightly reduced (Fig. 4J and K) . In addition to the defects described above, Fgfrl1a morphant larvae displayed a severely hypoplastic gastrointestinal tract and reduced swim bladder ( Fig. 4L and M) .
This specific ablation of the ceratobranchial elements was also evident using an ATGMO (68/181 at 1.5 pmol dose) designed to target the start site of fgfrl1a (Fig. 4A) . The 1aATGMO demonstrated a less penetrant phenotype than that observed within 1aSBMO-injected animals, with some ceratobranchial elements remaining (Fig. S2) . However, the cartilage defects were always specific to the ceratobranchial elements (Fig. S2 ). In the experiments that follow, the 1aSBMO was used to deplete Fgfrl1a activity.
Fgfrl1a is dispensable for normal neural crest migration
The abnormalities described above closely resembled those previously described in embryos depleted of Gcm2, a transcription factor dependent on Fgf3 signaling (Hanaoka et al., 2004; Hogan et al., 2004) . These observations led us to explore whether Fgfrl1a functions in skeletogenic pathways responsive to Fgf3 signaling.
To unravel the underlying developmental defect responsible for the morphant arch phenotype, we analyzed the induction and migration of neural crest cells destined to contribute to the pharyngeal arches. Fgf3 from the pharyngeal endoderm has been shown to be required for the specification and survival of chondrogenic neural crest cells of the branchial arches (David et al., 2002; Walshe and Mason, 2003) . To view this dynamic process in the absence of Fgfrl1a, we analyzed the expression of the post-migratory neural crest marker, dlx2 (Akimenko et al., 1994) , within Fgfrl1a morphant embryos.
In 23 somite-stage ($20 hpf) wildtype embryos, dlx2 expression marks each of the three neural crest streams (Fig. 5A ). An identical expression profile was observed in Fgfrl1a-depleted embryos (N = 29; Fig. 5B ). Following 26 h development, the posterior-most crest stream begins to segment into what will eventually constitute five distinct domains corresponding to the five branchial arches (Fig. 5C ). This segmentation initiated normally in the absence of Fgfrl1a (N = 43; Fig. 5D ) and by 48 hpf, dlx2-expressing neural crest cells populated the mandibular, hyoid and branchial arches in a typical fashion (Fig. 5E and F; N = 24) . These results were supported by further analysis of neural crest migration using the Fgf-dependent transcription factors erm (N = 66) and pea3 (N = 45) that also highlighted normal migration of the crest lineage to populate the arches in the absence of Fgfrl1a (Fig. 5G-N) . This normal neural crest cell migration into the arch primordia in the absence of Fgfrl1a closely resembled that reported within Gcm2-deficient animals (Hanaoka et al., 2004; Hogan et al., 2004) .
2.5. Fgfrl1a is essential for ectodermal gcm2 expression but not for pharyngeal ectoderm specification nor pouch endoderm segmentation Next, we investigated whether the observed similarities between the Fgfrl1a-and Gcm2-depleted phenotypes were due to a common absence of Gcm2 activity in the pharyngeal ectoderm. In 48 hpf zebrafish embryos, gcm2-expressing cells are localized in the ectodermal lining of the branchial arches (Fig. 5O) . This is in contrast to similarly staged Fgfrl1a-depleted embryos where no gcm2 expression was detectable (44/48; Fig. 5P ), strongly supporting the dependence of ectodermal gcm2 expression upon normal Fgfrl1a activity. This dependence of gcm2 expression upon Fgfrl1a was confirmed using the 1aATGMO (Fig. S2) . Although gcm2 expression was absent following Fgfrl1a knockdown, the ectoderm of the pharyngeal arches was present and specified normally as evidenced by normal sox9b expression at 72 hpf (N = 46; Fig. 5Q-T) . The transcription factor sox9b is expressed within the epithelial sheath of the pharyngeal arches from 68 hpf (Yan et al., 2005) .
Expression of fgf3 has been shown to be essential for ectodermal gcm2 expression (Hanaoka et al., 2004) . To establish whether this Fgfrl1a-dependent expression of gcm2 was an indirect effect due to a cell autonomous role for Fgfrl1a in pouch endoderm development and a subsequent absence of fgf3 signaling from the pouches, we analyzed both pouch segmentation and fgf3 expression in Fgfrl1a-depleted embryos. Segmentation of the pharyngeal pouches proceeded normally in the absence of Fgfrl1a, as evidenced by typical staining of the pouch endodermmarking antibody, Zn5 (Trevarrow et al., 1990 ) ( Fig. 5U and V; N = 64). In addition, in situ hybridization revealed that fgf3 expression was not dependent on Fgfrl1a ( Fig. 5W and X ; N = 48), and confirmed the normal segmentation of the pouch endoderm seen using the Zn5 antibody. The maintenance of pouch endoderm segmentation and fgf3 expression within Fgfrl1a morphants and the documented dependence of ectodermal gcm2 expression on Fgf3 signaling (Hanaoka et al., 2004) , positions Fgfrl1a as a potential mediator of Fgf3 signaling to induce gcm2 expression. In addition, gcm2 expression commences in the ectodermal lining of the ceratobranchial arches around 32 hpf (this study and Hanaoka et al., 2004; Hogan et al., 2004) , well after fgfrl1a and fgf3 expression commences in the pouch endoderm.
2.6. Fgfrl1a-depleted embryos fail to express sox9a and runx2b within mesenchymal condensations of the branchial arches To pinpoint when this cartilage defect was first detectable during chondrogenesis we examined the expression of sox9a and runx2b, two transcription factors that mark mesenchymal condensations within the developing arches and are absolutely required for normal chondrogenesis (Chiang et al., 2001; Yan et al., 2002; Flores et al., 2004; Flores et al., in press ).
Analysis of sox9a expression within the pharyngeal arches of 60 hpf wildtype larvae confirmed expression within the mesenchymal condensations during chondrogenesis ( Fig. 6A and C) . This was in contrast to similarly staged Fgfrl1a-depleted larvae in which transcripts for sox9a were only detected in the anterior-most, mandibular and hyoid, arches. No sox9a expression was detected within any of the developing branchial arches (79/90; Fig. 6B and D) . A similar result was obtained when analyzing runx2b expression in the absence of Fgfrl1a (70/79; Fig. 6F and H). Fgfrl1a morphants displayed maintenance of expression within the ethmoid plate and cleithrum, as well as the mandibular and hyoid arches, albeit slightly reduced. This, again, was in contrast to the branchial arches in which no transcripts were detected (Fig. 6E-H) .
This specific ablation of both sox9a and runx2b expression within the branchial arches supports the lack of ceratobranchial cartilage elements observed in Fgfrl1a morphant larvae and suggests that Fgfrl1a performs a non cell-autonomous role in the specification of skeletal progenitors within the branchial arches.
Fgfrl1b in the pharyngeal endoderm is indispensable for the formation of all pharyngeal cartilage
During the course of this study, it was reported that fish possess more than one copy of Fgfrl1 (Trueb et al., 2005) . Although Fgfrl1b is more divergent from the mammalian orthologs when compared with Fgfrl1a, both genes share many expression domains including the pharyngeal pouch endoderm (Fig. 7) . Early expression of fgfrl1b was detected in the mesendoderm of two somite embryos ( Fig. 7A and  B) . Distinct mesodermal expression was displayed in the lateral plate of 10 somite, and in the ventral tail of 18 somite embryos (Fig. 7C and D) . The endodermally derived hypochord expressed fgfrl1b in 10 somite embryos (Fig. 7C ). In addition, endodermal fgfrl1b positive cells later delaminated to populate the pharyngeal pouches, and the gut endoderm as seen in 26 hpf embryos (Fig. 7E-G) . Pharyngeal arch expression remained within the endodermal compartment during arch chondrogenesis as displayed by 36, 48 and 56 hpf embryos (Fig. 7H , J-L, O and P). Like fgfrl1a, 1b transcripts were detected in the developing lens, the pectoral fin buds and the gut anlagen (Fig. 7E, H, I and L-O). We next examined whether Fgfrl1b also influences formation of the head skeleton.
Depletion of Fgfrl1b using a SBMO (1bSBMO) targeting the splice donor site immediately downstream of the first exon (Fig. 8A ) demonstrated a dose-dependent reduction of normal transcript (Fig. 8B) . This was in contrast to the typical expression levels detected for the controls fgfrl1a and ef1-a (Fig. 8B) . Due to the exclusion of this ATG-encoding exon from 1bSBMO-modified fgfrl1b transcripts, the activity of Fgfrl1b should be completely inhibited when this MO is used.
Early delivery of the 1bSBMO into zebrafish embryos resulted in a dose-dependent depletion of posterior pharyngeal cartilage elements ( Fig. 8C and D) . At the 0.125 pmol dose, 20% (N = 45) of injected larvae displayed a depletion of ceratobranchial cartilage. This proportion increased to 30% (N = 82) and 58% (N = 83) with 0.25 and 0.5 pmol doses, respectively. Higher doses of 1bSBMO began to induce non-specific toxicity, typified by general necrosis within the developing head. At all doses for 1bSBMO, injected larvae maintained arch 1-and 2-derived cartilage elements and cranial cartilage ( Fig. 8D and G) . To validate this phenotype we employed a second ATG-targeting MO, 1bATGMO. Early delivery of this MO into zebrafish embryos also effected a dose-dependent depletion of ceratobranchial cartilage elements (6% (N = 90) and 50% (N = 69) with 0.0625 pmol and 0.25 pmol doses, respectively) (Fig. 8E) . However, 1bATGMO-injected larvae also displayed a dose-dependent depletion of the mandibular and hyoid cartilages. At higher doses of 0.25 and 0.5 pmol, formation of all ventral cartilages was compromised (28% (N = 69) and 94% (N = 66), respectively) (Fig. 8J) . In addition, in comparison to Fgfrl1a, 1b more profoundly influ- enced chondrogenesis in cranial components ( Fig. 8F and  H) . A subset of animals treated with 0.5 pmol 1bATGMO exhibited severely reduced cranial cartilage (Fig. 8J) suggesting that fgfrl1b is involved in the development of both pharyngeal and cranial cartilage components. A similar analysis using the 1bSBMO was precluded by the non-specific toxic effects of this MO at higher doses.
These results illustrate that both Fgfrl1a and 1b are necessary for posterior pharyngeal cartilage development. To investigate whether Fgfrl1a and 1b cooperate functionally during the development of the ceratobranchials, we injected sub-optimal doses of the 1aSBMO (0.125 pmol) and 1bATGMO (0.0625 pmol), alone and in combination. We used these two MOs as they effected the most penetrant phenotypes with no non-specific toxicity. Injected singly, the majority of animals assumed a normal skeletal morphology with either 1aSBMO (86%; N = 77), or 1bAT-GMO (94%; N = 90) (Fig. 8K and L) . When simultaneously delivered, 59% (N = 90) of the treated larvae lacked or had severely reduced ceratobranchial cartilage components (Fig. 8M) , suggesting cooperative activity between Fgfrl1a and 1b during ceratobranchial chondrogenesis. Of note, these animals maintained normal development of all arch 1-and 2-derived elements and cranial cartilage (Fig. 8M and N) . These results suggest that both duplicates, Fgfrl1a and 1b, are required for the proper formation of ceratobranchial cartilage, while Fgfrl1b appears to possess a broader role in the development of all pharyngeal and cranial cartilage.
Discussion
Fgfrl1a and 1b are both essential for ceratobranchial cartilage formation
In zebrafish, the synergistic activity of Fgf3 and Fgf8 ligands is an absolute requirement for the formation of the ventral head skeleton (Walshe and Mason, 2003; Crump et al., 2004) . Fgf expression in the pharyngeal pouches is an important component of a complex system that governs chondrogenic neural crest fate and pharyngeal arch formation (David et al., 2002) . We show here that Fgfrl1, a close relative of the FGFR family, represents a novel component of this system and is required for cartilage formation of the ceratobranchials. Larvae depleted of wildtype fgfrl1a transcripts by morpholino treatment resemble Fgf3 morphants (David et al., 2002; Walshe and Mason, 2003) and the Fgf3 mutant lia (Herzog et al., 2004) that lack cartilage in the posterior cb1-4 suggesting they both participate in the same developmental programme. However, while abolishing the Fgf3 signal does not seem to affect cartilage formation of the last teeth-bearing arches (cb5), these are absent in Fgfrl1a morphants. Nevertheless, cb5 is dependent on Fgf signaling as incubation with the pan-Fgfr inhibitor Su5402 abrogates all craniofacial structures (Walshe and Mason, 2003) . This indicates that other Fgf(s) must be responsible for cb5 morphogenesis. Fgf8 is the most likely candidate for this role. During morphogenesis of the zebrafish pharyngeal cartilage, Fgf3 and Fgf8 have been demonstrated to have both redundant and cumulative activities. While Fgf8 morpholino-targeted embryos develop pharyngeal cartilage, albeit slightly dysmorphic, treatment with both fgf3-and fgf8-targeting morpholinos completely abrogates chondrogenesis within the pharyngeal arches, essentially phenocopying pharmacological inhibition with Su5402 (David et al., 2002; Walshe and Mason, 2003) . These observations suggest that Fgf3 alone is essential for cartilage formation of cb1-4, while the mandibular and hyoid cartilages together with cb5 require the combined activity of both Fgf3 and Fgf8. Hence, Fgfrl1a may also modulate Fgf8 activity to signal to cb5.
The effect on cartilage development observed in Fgfrl1a-depleted larvae was specific for the ceratobranchials. Although, fgfrl1a is expressed within the mesenchymal interiors of the first two arches from 36 hpf, its role here appears to be non-essential. Interestingly, fgfrl1b is also expressed within the pharyngeal pouch endoderm and might compensate for the absence of Fgfrl1a in the anterior arches. Fgfrl1a SBMO did not affect transcript levels of fgfrl1b, and vice versa. Nevertheless, neither molecule was able to compensate for the absence of the other in the ceratobranchial arches. We infer that both are essential for chondrogenesis in these arches.
Fgfrl1a contributes to gill cartilage development by promoting gcm2 expression within the pharyngeal ectoderm
The craniofacial abnormalities resulting from depletion of Fgf signaling are due to requirements for Fgf3 and Fgf8 in multiple steps leading to pharyngeal cartilage formation. In zebrafish, differentiated cartilage is first detected after 2 days of development (Kimmel et al., 1995) . Initially, mesodermal and neural Fgf signals organize the segmentation of the pharyngeal endoderm into pouches during early somitogenesis (Crump et al., 2004) . During mid-somitogenesis, dlx2-positive cranial neural crest cells located alongside the brain migrate to populate the pharyngeal arches. Fgf-responsive transcription factors erm and pea3 are also expressed in these migratory neural crest cells. Pharyngeal pouch endoderm physically interacts with the crest mesenchyme, and endodermal Fgf3 and Fgf8 are crucial for their survival and differentiation (David et al., 2002; Crump et al., 2004) . Another target of Fgf3 signaling in the gill ectoderm, shown to be essential for chondrogenesis, is Gcm2 (Hanaoka et al., 2004) . Depletion of Gcm2 abolishes formation of all branchial cartilages (Hanaoka et al., 2004; Hogan et al., 2004; Okabe and Graham, 2004) . The genetic and epistatic analysis presented here permits consideration of the involvement of Fgfrl1a in many of the steps described above, each of which are crucial for proper branchial arch development.
Embryos lacking both Fgf3 and Fgf8 fail to form pouches from an otherwise normal endoderm due to a block in lateral migration of endodermal cells from the foregut sheet (Crump et al., 2004) . Pouch endoderm in the Fgf3-null mutant lia migrates medially but appears unsegmented (Herzog et al., 2004) . This is in contrast to the relatively mild pouch defects associated with the Fgf8 mutant, ace (Crump et al., 2004) . Taken together, it seems that Fgf3 is the main ligand required for proper patterning of the pouches, and the aberrant formation of the pouches in turn contributes to the abrogation of branchial arch chondrogenesis in the Fgf3 mutant. However, animals depleted of Fgf3 by morpholino injection lacked branchial cartilages despite typical pouch segmentation (David et al., 2002) , arguing for a separate and essential role for Fgf3 in the pouch endoderm to regulate pharyngeal arch chondrogenesis (Crump et al., 2004) . Our findings do not support a role for Fgfrl1a in the earlier event of pouch segmentation. First, we did not detect fgfrl1a transcripts in the mesoderm or hindbrain at 12-18 hpf to influence patterning of the pouch endoderm. Second, the Fgfrl1a morphants developed normal pharyngeal pouches as detected by the endodermal markers Zn5 and fgf3.
Next we looked at the influence of Fgfrl1a on chondrogenic neural crest cells. fgfrl1a is expressed within pouch endoderm from 24 hpf and within a subset of neural crest cells that constitute the first two arches from 36 hpf. In the Fgfrl1a morphant, the posterior neural crest stream destined to form the ceratobranchials had begun segmentation by 26 hpf, and was patterned normally by 48 hpf. Unlike Fgf3, but similar to Gcm2 (Hogan et al., 2004) , Fgfrl1a plays no obvious role in the specification and survival of the posterior-most stream of crest cells that make up the branchial arch mesenchyme. This was demonstrated by the retention of dlx2, erm and pea3 expression in Fgfrl1a morphants. Expression levels of both dlx2 and erm in the branchial neural crest stream were reduced in Fgf3 morphants (Walshe and Mason, 2003) . Hence, we eliminate a role for Fgfrl1a in the maintenance of endodermal pouches, and in the maintenance and migration of neural crest cells to the pharyngeal region during the genesis of the pharyngeal arches. However, following this colonization of the arch primordia with neural crest cells, the neural crest-derived mesenchyme within the branchial arches of Fgfrl1a-depleted animals fails to express sox9a and runx2b, two transcription factors that typically mark mesenchymal condensations and promote their differentiation into chondrocytes.
We propose that Fgfrl1a is required for Fgf signal transduction from the endoderm to the pharyngeal ectoderm to promote gill cartilage formation. Fgf3-dependent gcm2 expression in the pharyngeal ectoderm is believed to non cell-autonomously regulate arch neural crest differentiation into cartilage (Hanaoka et al., 2004) . In support of this dependence of skeletogenic neural crest cell development on ectodermal signaling, the transcription factors tfap2a and tfap2b have been shown to act redundantly within the ectoderm to regulate skeletogenic programmes within neural crest cells of the arches (Knight et al., 2005) . Fgfrl1a loss-of-function defects in the pharyngeal arches more closely resemble those of Gcm2 morphants, in that cb1-5 are missing, whereas only cb1-4 are affected in the Fgf3 mutant lia (Herzog et al., 2004) . Expression of fgfrl1a and fgf3 in the pouch endoderm commences around 24 hpf, preceding that of gcm2 in the arch ectoderm, which is first detected at 32 hpf (this study and Hanaoka et al., 2004; Hogan et al., 2004) . Similar to effects seen when Fgf3 is depleted, expression of gcm2 in the pharyngeal epithelium is completely abolished in Fgfrl1a morphants. In addition, this loss of gcm2 expression is not a secondary effect due to a role for Fgfrl1a in pharyngeal ectoderm development, as evidenced by the maintenance of epithelial sox9b expression. In contrast to Fgf3-deficient animals, Fgfrl1a and Gcm2 morphants display normal expression of dlx2 in the mesenchyme at 48 hpf. However, within the branchial arches, condensations of these cells subsequently fail to differentiate into chondrocytes, as evidenced by their failure to express sox9a and runx2b, as well as the specific ablation of ceratobranchial cartilage elements. This corroborates a convergent role for Fgfrl1a and Gcm2 in the maintenance and/or differentiation of the branchial arch mesenchyme to cartilage, but not in early neural crest cell specification, survival and migration to the pharyngeal region.
These data suggest a cascade whereby signaling from the endoderm, where Fgf3, Fgf8 and Fgfrl1a are co-localized, is required for the production of Gcm2 in the ectoderm, where it triggers another signaling outcome to the mesenchymal cells in the core of the arches (Hanaoka et al., 2004) . Precedence does exist for endoderm-ectoderm signaling during early jaw morphogenesis (Harworth et al., 2004) . Harworth and colleagues showed that Fgf8 expression within the murine ectodermal epithelium required the presence of endoderm, suggesting that early patterning of the ectoderm is regulated, in part, by the endoderm. We also observed that several other aspects of the Gcm2 morphant phenotype were reproduced in the Fgfrl1a loss-of-function model. In particular, affected animals had hypoplastic gastrointestinal tracts (Hogan et al., 2004) . Given that both fgf3 and gcm2 are expressed in the gut along with fgfrl1a (this study and Hanaoka et al., 2004) , it is tantalizing to speculate that a conserved molecular relationship might exist in the context of the developing gut.
How does Fgfrl1a act?
Overlapping expression of fgfrl1a with fgf3 and fgf8 in the developing arches, their convergent function in a common developmental pathway and the ability of FGFRL1 to interact with both heparin and FGF ligand (Sleeman et al., 2001; Trueb et al., 2003) positions Fgfrl1a as a candidate component of Fgf signaling during craniofacial development.
Exactly how Fgfrl1a modulates Fgf signaling remains unknown. Given that Fgfrl1a does not possess a kinase domain (Sleeman et al., 2001; Trueb et al., 2003) it cannot directly transduce an Fgf signal and would require the recruitment of adaptor protein(s) at the cytoplasmic domain to activate an intracellular signaling cascade. While this scenario cannot be excluded, it would seem unlikely given that Trueb et al. (2003) were unable to identify any binding partners in a yeast two-hybrid screen with mouse FGFRL1. This lack of a kinase domain has led some to suggest that FGFRL1 may function as a decoy receptor to sequester free FGF ligand (Trueb et al., 2003) . Given that our loss-of-function model phenocopied a reduction in Fgf3, both morphologically (with respect to ceratobranchial arch formation) and genetically (absence of ectodermal gcm2 expression) we feel that it is unlikely that Fgfrl1a functions as a decoy, at least within the pharyngeal pouch endoderm.
Fgfrl1a could participate in Fgf-induced signaling through cooperating with other FGF receptors. This scenario seems plausible given that other transmembrane proteins have been demonstrated to modulate Fgf signaling via Fgf receptors, like the inhibitor Sef in zebrafish (Furthauer et al., 2002; Tsang et al., 2002) , and the positive co-receptor in Xenopus, XFLRT3 (Bottcher et al., 2004) . Having no obvious signaling domain, or the capacity to bind Fgf ligand, both are thought to physically interact with Fgf receptors to transduce their activity.
It is of note that there are two tyrosine residues within the intracellular domain of Fgfrl1a (residues 454 and 458) that are conserved between the fish, chicken, amphibian and mammalian sequences. These residues reside within an intracellular portion of the protein that displays the greatest degree of identity and has been suggested to contain SHP-like binding motifs in the murine ortholog (Sleeman et al., 2001) . Although these residues, like that in the fish, do not exactly match the SHP binding consensus motif, they may impart some signaling capacity.
In summary, depletion of Fgfrl1a is sufficient to abolish expression of gcm2 in the pharyngeal epithelium, and cause loss of ceratobranchial cartilage via the lack of specification of skeletogenic precursor cells within the branchial arches. We postulate that Fgfrl1a cooperates with Fgfs, in particular Fgf3, in this role.
Given the colocalized expression of fgfrl1a with its paralogue, fgfrl1b, within the pharyngeal endoderm and their synergistic activity during the development of ceratobranchial cartilage it seems likely that, at least in the context of the developing posterior pharyngeal arches, Fgfrl1a performs its function cooperatively with Fgfrl1b.
Experimental procedures
Phylogenetic analysis
The ClustalW algorithm was employed to align the full-length amino acid sequences of FGFRL1 and FGFR proteins. From this, tree reconstruction was performed using the neighbor-joining method and percent bootstrap values derived from 1000 replications. GenBank Accession Nos: Drosophila DFR1, X74030; Dugeisa japonica NDK, AB071948; human FGFR1, NM_000604; rat FGFR1, NM_024146; mouse FGFR1, NM_010206; chicken FGFR1, NM_205510; Xenopus Fgfr1, BC077548; zebrafish Fgfr1, NM_152962; human FGFR2, NM_000141; rat FGFR2, XM341940; mouse FGFR2, NM_010207; chicken FGFR2, NM_205319.1; Xenopus Fgfr2, BC073456; zebrafish Fgfr2, NM_178303; human FGFR3, NM_000142; rat FGFR3, NM_053429; mouse FGFR3, NM_008010; Xenopus Fgfr3, AB007035; zebrafish Fgfr3, NM_131606; human FGFR4, NM_213647; rat FGFR4, XM_344570; mouse FGFR4, BC033313; Xenopus Fgfr4, AB007036; zebrafish Fgfr4, NM_131430.
Zebrafish stocks and embryo collection
Zebrafish (Danio rerio) embryos were obtained from natural spawning between wildtype (AB, Oregon stock centre) adult fish. Embryos were raised at 28°C in Embryo Medium (E3) (Westerfield, 2000) and staged according to Kimmel et al. (1995) . Research was conducted with approval from the University of Auckland Animal Ethics Committee.
Whole-mount in situ hybridization, riboprobe synthesis and immunohistochemistry
A cDNA template encoding zebrafish Fgfrl1a was generated by RT-PCR using total RNA extracted from 24 hpf zebrafish embryos. fgfrl1a was amplified using primers fgfrl1aUP, 5 0 GAGGAACAGATTTCTG ATCATACTTTC 3 0 and fgfrl1aDO, 5 0 CATTTGTTTGTTACCCTTG CCC 3 0 . A 1668 bp amplicon was generated encompassing the entire open reading frame (ORF) of fgfrl1a and cloned into the pGEM-T Easy vector (Promega) for sequencing verification and probe synthesis. RNA probes were synthesized using a DIG RNA labeling kit (Roche). Probes for erm, fgf3, fgfrl1b and pea3 were also generated in a similar fashion using the following primer pairs: ermUP, 5 0 AGAAGCAAGCGACATGGA TGG 3 0 and ermDO, 5 0 ATGCATTCGAGAGTTCTTCT GG 3 0 ; fgf3UP, 5 0 CTGCTCTTGTTGTTACTGAGC 3 0 and fgf3DO, 5 0 TGTCAGCCCT TCTGTTGTGG 3 0 ; fgfr l1bUP, 5 0 CATCGGTGAGTCGTCCTGTA GAG 3 0 and fgfrl1bDO, 5 0 GAGTTGACCACAATAATGGAGTTCG 3 0 ; pea3UP, 5 0 GTGGAGC TCATTAAAACACAGC 3 0 and pea3DO, 5 0 GGCATGTGCAATAGGTGCAGC 3 0 . The template used for generating runx2b antisense probe is as described in Flores et al. (2004) . Primers fgfrl1bUP/DO generated a 2642 bp amplification product that started 77 nucleotides within the ORF of fgfrl1b and included approximately 1.27 kb of 3 0 UTR sequence. Whole-mount in situ hybridizations were performed essentially as described by Jowett and Lettice (1994) . Pigmentation in embryos older than 24 hpf was inhibited using PTU (I-phenyl-2-thiourea; Sigma) as described by Westerfield (2000) .
Immunohistochemistry was performed essentially as described by Macdonald (1999) . The Zn5 antibody (Trevarrow et al., 1990 ) and secondary goat anti-mouse IgG peroxidase-conjugate (Sigma) were both used at 1:300 dilutions.
Injection of morpholino oligonucleotides
Morpholinos (Gene Tools, Philomath, OR) were prepared and injected as described (Nasevicius and Ekker, 2000) . The morpholino oligonucleotides used in this study and their sequences were: 1aSBMO, 5 0 TGTGTGA CTCACGGATGACTTCCAC 3 0 and 1bSBMO, 5 0 GAATAAAAGACTC ACCTCTCGCTTC 3 0 (sequences in bold and italics represent sequence complementary to intronic and coding sequences, respectively); 1aATGMO, 5 0 ACTATCCAAAGAAGTTCCATGATGT 3 0 and 1bAT-GMO, 5 0 CCTCTCTCTGGAAACATTTTATGAC 3 0 (sequence complimentary to start codon are underlined); and Oep MO, 5 0 GCCAATAAAC TCCAAAACAACTCGA 3 0 (Feldman and Stemple, 2001 ).
Semi-quantitative RT-PCR
First strand cDNA was generated using total RNA isolated from wildtype and SBMO-injected 32 hpf embryos using Trizol (Life Technologies). The linear amplification ranges were determined for each of the following primer sets: fgfrl1aA, 5 0 CAAAATGAGAAAGCGTGTGATTGC 3 0 and fgfrl1aB, 5 0 CTTGACATCACTGCGTACTTTGC 3 0 , that generate a 367 bp amplicon; fgfrl1bUP/C and fgfrl1bDO/B; fgfrl1bA, 5 0 GTGGCGG GTCATAAAATGTTTCC 3 0 and fgfrl1bD, 5 0 CTTCAGACTTCGCTT CAGGACC 3 0 , that generate a 261 bp amplicon; ef1aUP, 5 0 ATCTACA AATGCGGTGGAAT 3 0 and ef1aDO, 5 0 ATACCAGCCTCAAACTCA CC 3 0 , that generate a 279 bp amplicon. The binding sites for primers fgfrl1aA and B are located within exons encoding the Ig2-and Ig3-like domains of Fgfrl1a, respectively. These exons juxtapose the splice donor site targeted by the 1aSBMO. The binding site for primer fgfrl1aC (5 0 CTGTT GCTGCATGTTCAATCTACG 3 0 ) is located within intronic sequence between the Ig2-and Ig3-encoding exons and when used in combination with fgfrl1aA amplifies a 355 bp product from genomic template DNA.
Alcian blue staining
To visualize craniofacial cartilage, zebrafish larvae were stained with alcian blue (Sigma) as described by Schilling et al. (1996) .
Sectioning
Larvae to be sectioned were dehydrated in methanol and embedded in JB-4 methacrylate (Polysciences). Sections 5-8 lm thick were cut using a RM2155 microtome (Leica) and transferred to glass slides, counterstained with Nuclear Fast Red (Vector Laboratories, Inc.) and mounted with Poly-Mount (Polysciences).
Microscopy and imaging
Zebrafish embryos and larvae were observed and manipulated under a Leica MZFLIII microscope. Sectioned larvae were analyzed under a Leica DMR compound microscope. Images were captured using a Leica DC200 digital camera and supporting software.
